Clinical Studies

The Guided Transfer study investigates the effects of a guided transfer model to transition patients with chronic endocrinology conditions from pediatric to adult endocrinology clinic. Participants are eligible if they meet the following criteria: 

• T1D or Chronic Endo condition for > 1 yr & ready to transition to Stanford Adult Endocrinology Care
• English-speaking
• Followed in Stanford-affiliated pediatric endo clinics (Dr. Rayhan Lal’s patients excluded)
•  ≥ 16 years

If you would like more information about this study, please contact Marci Morgan at [email protected] or 702-279-7870.

The PEDAP-AI study will explore how Artificial Intelligence (AI) can help doctors choose insulin pump settings in a system that uses automated insulin delivery. The study is sponsored by the NIH. All children who take part will get to use the study insulin pump, pump supplies and other study devices while in the study. The study lasts about 8 weeks. 

Participants may be eligible if they meet the following criteria: 

• Diagnosis of type 1 diabetes for at least 3 months
• Age ≥2 and <6 years old
• Participant's cannot be already using an insulin pump
• Using a Dexcom CGM at the time of enrollment, with use of at least 21 out of the prior 28 days
• Total daily insulin dose (TDD) at least 5 Units/day
• Body weight at least 20 pounds (lbs)
• Parent/guardian proficient in reading and writing English
• Live in California, Colorado or Virginia, with no plans to move outside these states during the study period
   

If you would like more information about this study, please contact Ryan Kingman at [[email protected]](mailto:[email protected]) or (650) 736-441.

The purpose of this screening questionnaire is to create a clinical research registry from which investigators within the Stanford Diabetes Research Center can recruit participants. In order to find out whether you are eligible for particular studies, you will be asked to complete a pre-screening questionnaire. There are two steps involved in this pre-screening process: 1) consent to be screened via the questionnaire, and 2) if you agree to the consent, complete the online screening questionnaire to determine whether you are eligible to attend an in-person screening visit with one or more groups part of the Stanford Diabetes Research Center in the near or distant future. Your information will be kept as confidential as possible as required by law. This survey is encrypted for additional security.

For more information, visit the following link: https://redcap.stanford.edu/surveys/?s=FL8HKMDRCC 

The Time in Tighter Range – Possible Psychological Impacts in Adults with Type 1 Diabetes study at Stanford investigates participant experiences with the metric of “time in range,” or “time in glucose target range,” to improve practices and help other patients using a continuous glucose monitor follow recommended clinical guidelines. Patient perspectives on diabetes clinical care recommendations need to be studied and understood.

What does the study involve?

• Discussing the study with the study team and completing the consent if you would like to participate (30 minutes and can be done in person or via Zoom)
• Complete 1 focus group or interview
• The focus group or interview will take approximately 60 minutes via Zoom
• You will receive $50 for participating

Am I eligible? Are you:

• Between the ages of 18-80 years old?
• Diagnosed with type 1 diabetes?
• Wearing a continuous glucose monitor?
• Then Yes!

If interested, please email [email protected] or call (650) 723-3383 to schedule a time to discuss the study in more detail.

Stanford researchers created a survey to SHARE YOUR EXPERIENCE with managing #type1diabetes when participating in water-based activities! Fill out the survey here: https://bit.ly/t1dwater